Can Ellex’s 2RT Nanosecond Laser Halt the Progression of Macular Degeneration?
February 21, 2013
A new double-blind, randomized clinical trial is currently underway at the Center for Eye Research Australia (CERA) to determine whether the 2RT nanosecond laser manufactured by Ellex Medical Lasers Ltd can be utilized to slow the progression of age-related macular degeneration in patients with early stage AMD.
The laser emits a tiny pulse of energy into the back of the eye to remove the deposits that build up with age and contribute to AMD. Patients report that the treatment was completely painless.
The treatment is not suitable for people who have already developed the advanced form of AMD, either the dry or the wet form.
Jump down to form below to submit your own comments